Viking Therapeutics
VKTX
#2800
Rank
C$6.76 B
Marketcap
$60.72
Share price
-0.24%
Change (1 day)
139.31%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -C$0.14 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$0.13 Billion a decrease over its 2022 earnings that were of -C$99.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.14 Billion8.34%
2023 -C$0.13 Billion24.73%
2022 -C$99.05 Million25.24%
2021 -C$79.09 Million39.23%
2020 -C$56.81 Million53.21%
2019 -C$37.08 Million16.84%
2018 -C$31.74 Million7.22%
2017 -C$29.6 Million39.68%
2016 -C$21.19 Million-37.05%
2015 -C$33.66 Million6.94%
2014 -C$31.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.72 Billion 400.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.41 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.64 M-119.39%๐Ÿ‡บ๐Ÿ‡ธ USA